Subscriptions Central AfricaEast AfricaHorn of AfricaIndian OceanNorth AfricaSouthern AfricaWest AfricaAfrica / World Agriculture - NutritionCulture - ArtsEconomy - DevelopmentEnvironment - NatureGay - LesbianGender - WomenHealthHuman rightsLabourMediaPoliticsScience - EducationSocietyTechnologyTravel - Leisure From Behind By Country By Topic Chronological Press Releases Partner Media Contact Us
Theory of a connection between an experimental polio vaccine and the origin of HIV


Theory of a connection between an experimental polio vaccine and the origin of HIV

Related items

Pages
News, Africa 
Health News 
Health & Medicine Index Page 
Women's Health Index Page 

Background
» Theory of a connection between an experimental polio vaccine and the origin of HIV 
» HIV & AIDS in Africa now 
» Abuse of women escalates HIV infections in Africa 
» Women's health at risk in Africa 

In Internet
UNAIDS 
WHO 
AfricaNews - Health 

Since the beginning of the AIDS epidemic, there has been much speculation in both the scientific literature and in the popular press on the origin of HIV, the virus that causes AIDS. One theory, that HIV was spread to the general population by an experimental polio vaccine used in Central Africa in the 1950's. The WHO now has found sufficient proof to reject this theory. 

This theory has especially been detailed by Mr. Edward Hooper in his book, The River (1999). This theory is not new. It has been described by other authors and was previously rejected by an independent panel of experts. 

In his book, Mr Hooper outlines studies that needed to be completed in order to rule out the possibility that HIV was spread to the general population by an experimental polio vaccine. This included the testing of the retained samples of the experimental vaccine for the HIV, SIV (Simian Immunodeficiency Virus) and chimpanzee DNA. (The hypothesis states the vaccine was produced using chimpanzee kidneys.)

New Scientific Findings
In September 2000, the Royal Society in London met to examine the origin of HIV. Mr Hooper's theory was one of several hypotheses being considered. 

The following scientific findings presented to the Royal Society further reject Mr Hooper's hypothesis.

  • Genetic sequencing data suggests that HIV first entered the human population around 1930, well before the vaccine trials of the 1950's.
  • Using ultra sensitive molecular methods, the experimental polio vaccine samples (which have been in safe storage since the late 1950s), have recently been tested, and are negative for HIV, SIV and chimpanzee DNA. The latter finding rules out the hypothesis that chimpanzee kidneys were used in the preparation of these experimental vaccine samples.
  • Moreover, the process used to manufacture the vaccine would not permit the experimental vaccine to be contaminated with HIV or SIV. Production of the experimental vaccine included treatment with trypsin (a powerful enzyme), freezing, thawing and filtration, each of which is known to destroy or remove HIV and SIV. This process would not support the transfer of HIV to the final vaccine product.

Implications 
These new findings are consistent with other epidemiological, biological and virological evidence and indicate that Mr Hooper's hypothesis cannot be substantiated. 

The Sabin strain of the oral polio vaccine used in polio immunization is in NO WAY related to the experimental vaccine questioned by Mr Hooper (the "CHAT" vaccine). Modern vaccines are always tested before use and DO NOT contain HIV or SIV. 

Oral Polio Vaccine (OPV) is safe and effective and the recommended vaccine for the global effort to eradicate polio and certify the world polio-free by 2005. It is the only vaccine proven to stop transmission of the virus in developing countries. Using this vaccine, the global campaign to eradicate polio has achieved a more than 95 per cent decrease in the number of polio cases world-wide in the twelve years since it was launched, and is on track to eradicate the disease. 

Source: WHO

© afrol.com. Texts and graphics may be reproduced freely, under the condition that their origin is clearly referred to, see Conditions.

   You can contact us at mail@afrol.com